Soumya S. Ray

2.9k total citations
41 papers, 2.2k citations indexed

About

Soumya S. Ray is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Soumya S. Ray has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Neurology and 7 papers in Physiology. Recurrent topics in Soumya S. Ray's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Protein Structure and Dynamics (6 papers) and Computational Drug Discovery Methods (6 papers). Soumya S. Ray is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Protein Structure and Dynamics (6 papers) and Computational Drug Discovery Methods (6 papers). Soumya S. Ray collaborates with scholars based in United States, India and Spain. Soumya S. Ray's co-authors include Peter T. Lansbury, Gregory D. Cuny, Richard J. Nowak, Robert H. Brown, Min Liu, P. Balaram, Deborah J. Woolf, S.J. Gamblin, Stephen C. Harrison and Bruce A. Harris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Soumya S. Ray

41 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soumya S. Ray United States 27 1.4k 343 332 291 272 41 2.2k
Miklós Guttman United States 28 1.3k 0.9× 120 0.3× 264 0.8× 93 0.3× 129 0.5× 76 2.3k
Frank J. Schoenen United States 27 1.5k 1.1× 132 0.4× 154 0.5× 206 0.7× 65 0.2× 76 3.0k
Rick Gussio United States 33 1.9k 1.3× 400 1.2× 175 0.5× 106 0.4× 71 0.3× 70 3.6k
Stéfano Ricagno Italy 28 1.4k 1.0× 56 0.2× 220 0.7× 451 1.5× 274 1.0× 83 2.0k
Junpeng Deng United States 26 1.2k 0.9× 298 0.9× 32 0.1× 115 0.4× 103 0.4× 57 1.9k
James C. Burnett United States 26 928 0.7× 508 1.5× 164 0.5× 64 0.2× 74 0.3× 57 1.9k
Michael D. W. Griffin Australia 32 2.0k 1.4× 77 0.2× 98 0.3× 579 2.0× 653 2.4× 122 3.1k
Ana P. C. Rodrigues United States 6 1.6k 1.1× 33 0.1× 157 0.5× 227 0.8× 248 0.9× 6 2.3k
Ganesha Rai United States 26 1.3k 0.9× 54 0.2× 104 0.3× 98 0.3× 61 0.2× 90 2.2k
Ilene M. Reardon United States 24 1.3k 0.9× 25 0.1× 424 1.3× 511 1.8× 198 0.7× 35 2.3k

Countries citing papers authored by Soumya S. Ray

Since Specialization
Citations

This map shows the geographic impact of Soumya S. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soumya S. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soumya S. Ray more than expected).

Fields of papers citing papers by Soumya S. Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soumya S. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soumya S. Ray. The network helps show where Soumya S. Ray may publish in the future.

Co-authorship network of co-authors of Soumya S. Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Soumya S. Ray. A scholar is included among the top collaborators of Soumya S. Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soumya S. Ray. Soumya S. Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Díaz, Lucía, et al.. (2025). Optimizing drug design by merging generative AI with a physics-based active learning framework. Communications Chemistry. 8(1). 238–238. 2 indexed citations
2.
Vemulapalli, Vidyasiri, Katherine A. Donovan, T.C.M. Seegar, et al.. (2021). Targeted Degradation of the Oncogenic Phosphatase SHP2. Biochemistry. 60(34). 2593–2609. 32 indexed citations
3.
Mazzonna, Marco, Debora Russo, Ilaria Penna, et al.. (2020). Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors. Journal of Medicinal Chemistry. 63(24). 15821–15851. 13 indexed citations
4.
Hauser, Kevin, Christopher Negron, Steven K. Albanese, et al.. (2018). Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations. Communications Biology. 1(1). 70–70. 64 indexed citations
5.
Suebsuwong, Chalada, Daniel M. Pinkas, Soumya S. Ray, et al.. (2018). Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(4). 577–583. 18 indexed citations
6.
7.
Suebsuwong, Chalada, Soumya S. Ray, Roshan J. Thapa, et al.. (2015). Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1. Cell Reports. 10(11). 1850–1860. 115 indexed citations
8.
Lang, Christian A., Soumya S. Ray, Min Liu, Ambuj K. Singh, & Gregory D. Cuny. (2015). Discovery of LRRK2 inhibitors using sequential in silico joint pharmacophore space (JPS) and ensemble docking. Bioorganic & Medicinal Chemistry Letters. 25(13). 2713–2719. 19 indexed citations
9.
Canning, Peter, Tobias Schwerd, Matouš Hrdinka, et al.. (2015). Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors. Chemistry & Biology. 22(9). 1174–1184. 77 indexed citations
10.
Pytel, Dariusz, Kathleen Seyb, Min Liu, et al.. (2014). Enzymatic Characterization of ER Stress-Dependent Kinase, PERK, and Development of a High-Throughput Assay for Identification of PERK Inhibitors. SLAS DISCOVERY. 19(7). 1024–1034. 22 indexed citations
11.
Ray, Soumya S. & Min Liu. (2012). Current Understanding Of LRRK2 In Parkinson’s Disease: Biochemical And Structural Features And Inhibitor Design. Future Medicinal Chemistry. 4(13). 1701–1713. 35 indexed citations
12.
Kirubakaran, Sivapriya, Suresh Kumar Gorla, Lisa Sharling, et al.. (2012). Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. Bioorganic & Medicinal Chemistry Letters. 22(5). 1985–1988. 43 indexed citations
13.
Liu, Min, Soumya S. Ray, Justin Jackson, et al.. (2011). Kinetic, Mechanistic, and Structural Modeling Studies of Truncated Wild-Type Leucine-Rich Repeat Kinase 2 and the G2019S Mutant. Biochemistry. 50(43). 9399–9408. 39 indexed citations
14.
Ray, Soumya S., Richard J. Nowak, Robert H. Brown, & Peter T. Lansbury. (2005). Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proceedings of the National Academy of Sciences. 102(10). 3639–3644. 121 indexed citations
15.
Ray, Soumya S., et al.. (2004). Crystal Structure of the Flagellar σ/Anti-σ Complex σ28/FlgM Reveals an Intact σ Factor in an Inactive Conformation. Molecular Cell. 14(1). 127–138. 99 indexed citations
16.
Ray, Soumya S., J.B. Bonanno, Hua Chen, et al.. (2002). X‐ray structure of an M. jannaschii DNA‐binding protein: Implications for antibiotic resistance in S. aureus. Proteins Structure Function and Bioinformatics. 50(1). 170–173. 19 indexed citations
17.
Ray, Soumya S., J.B. Bonanno, K.R. Rajashankar, et al.. (2002). Cocrystal Structures of Diaminopimelate Decarboxylase. Structure. 10(11). 1499–1508. 47 indexed citations
18.
Ray, Soumya S., Hemalatha Balaram, & P. Balaram. (1999). Unusual stability of a multiply nicked form of Plasmodium falciparum triosephosphate isomerase. Chemistry & Biology. 6(9). 625–637. 13 indexed citations
19.
Ray, Soumya S., B. Gopal, Srinivasan Parthasarathy, et al.. (1999). Disulfide engineering at the dimer interface of lactobacillus casei thymidylate synthase: Crystal structure of the T155C/E188C/C244T mutant. Protein Science. 8(4). 930–933. 17 indexed citations
20.
Ray, Soumya S., et al.. (1997). Triosephosphate isomerase from Plasmodium falciparum:. the crystal structure provides insights into antimalarial drug design. Structure. 5(6). 751–761. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miklós Guttman Breakdown of academic impact, for papers by Frank J. Schoenen Breakdown of academic impact, for papers by Rick Gussio Breakdown of academic impact, for papers by Stéfano Ricagno Breakdown of academic impact, for papers by Junpeng Deng Breakdown of academic impact, for papers by James C. Burnett Breakdown of academic impact, for papers by Michael D. W. Griffin Breakdown of academic impact, for papers by Ana P. C. Rodrigues Breakdown of academic impact, for papers by Ganesha Rai Breakdown of academic impact, for papers by Ilene M. Reardon
Rankless by CCL
2026